
|Podcasts|July 29, 2022
Pharmacy Focus: Psychedelic Pharmacy - Investigating Ketamine for Chronic Pain Management, Addiction Treatment
This month, we spoke with Tiago Reis Marques, MD, PhD, CEO of Pasithea Therapeutics, about ketamine and the future of the opioid epidemic.
Advertisement
This month, we spoke with Tiago Reis Marques, MD, PhD, CEO of Pasithea Therapeutics, about how investigative psychedelic treatments could help treat both chronic pain as well as addiction, and what this could mean for the future of the opioid epidemic.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights
1
Icotrokinra Outperforms Deucravacitinib in Head-to-Head Psoriasis Study
2
Dato-DXd Shows Promise as First-Line Therapy in Metastatic TNBC
3
From Policy to Practice: How the ACC Legislative Conference Advances Cardiovascular Care
4
FDA Approves Roflumilast Cream for Pediatric Patients With Atopic Dermatitis
5